Fulgent Genetics
FLGT
176 hedge funds and large institutions have $276M invested in Fulgent Genetics in 2025 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 36 closing their positions.
641% more call options, than puts
Call options by funds: $6.92M | Put options by funds: $935K
26% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 50
2.77% less ownership
Funds ownership: 55.63% → 52.86% (-2.8%)
7% less funds holding
Funds holding: 189 → 176 (-13)
12% less capital invested
Capital invested by funds: $314M → $276M (-$38.5M)
31% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$7.6M |
| 2 |
Millennium Management
New York
|
+$7.45M |
| 3 |
D.E. Shaw & Co
New York
|
+$5.27M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.56M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$2.82M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$27.5M |
| 2 |
Morgan Stanley
New York
|
-$6.16M |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.32M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.8M |
| 5 |
JP Morgan Chase
New York
|
-$3.63M |
FLGT Hedge Fund Activity: Q1 2025 in Review
176 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2025, worth a combined $276M — down 12% from $314M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of FLGT and 25 opened new positions — a net loss of 11 holders — while 50 trimmed existing stakes and 63 added.
The largest buyer was Acadian Asset Management, adding an estimated $7.6M. The largest seller was BlackRock, cutting an estimated $27.5M.
- 176 institutional investors held Fulgent Genetics (FLGT) as of Q1 2025, down from 189 in Q4 2024.
- Funds reported $276M of Fulgent Genetics stock for Q1 2025, down 12% quarter-over-quarter.
- 25 funds opened new Fulgent Genetics positions in Q1 2025 and 36 closed out, a net change of -11 holders.
- The largest Fulgent Genetics buyer in Q1 2025 was Acadian Asset Management, an estimated $7.6M added.
- The largest Fulgent Genetics seller in Q1 2025 was BlackRock, an estimated $27.5M sold.
Based on aggregated 13F filings for Q1 2025.